Alkermes Analyzes Avadel's Announcement Regarding Potential Acquisition Alkermes assesses Avadel Pharmaceuticals' recent announcement about a potential acquisition offer from H. Lundbeck A/S, revealing strategic considerations.

Alkermes Analyzes Avadel's Announcement Regarding Potential Acquisition #USA #Dublin #Lundbeck #Alkermes #Avadel

Alkermes Responds to Avadel's Potential Acquisition Offer by Lundbeck Alkermes plc has acknowledged Avadel Pharmaceuticals' recent announcement concerning a potential acquisition bid from Lundbeck, evaluating its options.

Alkermes Responds to Avadel's Potential Acquisition Offer by Lundbeck #USA #Dublin #Lundbeck #Alkermes #Avadel

Alkermes plc to Enhance Portfolio with Avadel Pharmaceuticals Acquisition Alkermes plc has announced a definitive agreement to acquire Avadel Pharmaceuticals, enhancing its commercial offerings, particularly in sleep medicine. Expected completion is in early 2026.

Alkermes plc to Enhance Portfolio with Avadel Pharmaceuticals Acquisition #Ireland #Dublin #Alkermes #Avadel #LUMRYZ